狂犬病病毒糖/核蛋白基因疫苗中间试验生物安全评价
肖跃强,张守峰,袁慧君,扈荣良
军事医学科学院军事兽医研究所,军事医学科学院军事兽医研究所,河南职业技术师范学院
,军事医学科学院军事兽医研究所 长春130062
,长春130062
,长春130062
Evaluation on the biosafety for the rabies virus glycoprotein/nucleoprotein DNA vaccine in dogs
摘要 目的 本试验应用狂犬病病毒糖/核蛋白“二价”DNA疫苗- pVGN免疫4 0条无狂犬病疫苗免疫史的家犬,共免疫3次。通过观察受试犬的临床表现,监测抗性基因的转移,检测质粒及其主要元件在主要脏器和注射组织的分布、存留及整合,观察主要脏器组织病理学变化,分析疫苗对妊娠母犬及其子代的影响,来评价该疫苗的生物安全性。结果表明,该DNA疫苗可在动物体内诱导良好的体液免疫反应。同时,受试犬未出现任何异常临床表现;DNA疫苗中的卡那霉素抗性基因未在免疫犬肠道正常菌群中发生转移,DNA质粒也未经肠道菌群、尿液和唾液排放到体外;在心、脾、肾和注射部位均能检测到质粒的存在,并分别能存留约18、14 - 18、14和2 6周以上,但质粒DNA未与上述组织的基因组DNA发生整合;在主要代谢器官肝脏中始终未检测到质粒DNA或其主要元件;上述各主要脏器未出现组织病理学变化;对妊娠母犬和其子代无不良影响。说明本狂犬病“二价”DNA疫苗不仅具有良好的免疫原性,而且具有很好的安全性。
关键词 :
狂犬病 ,
基因疫苗 ,
pVGN ,
安全性评价 ,
犬
Abstract :Forty un-vaccinated dogs were immunized with rabies virus glycoprotein/nucleoprotein bivalent DNA vaccine pVGN for 3 times, and the biosafety was evaluated by means of the observation on the development of immune responses in the immunized dogs, monitoring the transference of the kanamycin-resistance gene, detection of the distributions of plasmid in the main organs and the injected tissues; observations of the pathological changes in the main organs as well as analysis of the influences of vaccine on the pregnant dogs and their puppies. The result showed that this DNA vaccine could induce excellent humoral immune responses in the immunized dogs without any abnormal clinical responses observed. Transference of the kanamycin-resistance gene in the DNA vaccine to the normal intestinal flora did not occur, and this gene was also not excreted into surroundings through intestinal flora, urine and saliva. The plasmid could be detected in heart, kidney and the injected tissues, and persisted in these area for 18, 14~18, 14 and 26 weeks respectively, while it could not be detected in liver. No integration of the plasmid DNA with the genomic DNA in the above-mentioned area was found. Also, there were no histopathological changes observed in the main organs. The vaccine had no influence on the pregnant dogs and their puppies. It indicates that this bivalent DNA vaccine not only possess the satisfied immunogenicity, but also has no problem on biosafety.
Key words :
rabies
genetic vaccine
pVGN
evaluation on biosafty
dogs
收稿日期: 2005-04-20
〔1〕袁慧君,扈荣良,包世俊,等.狂犬病病毒糖、核蛋白基因疫苗的构建及在小鼠的免疫试验〔J〕.中国兽医学报,2004,24(2):141-144.
〔2〕J萨姆布鲁克,DW拉赛尔.分子科隆实验指南第3版〔M〕.黄培堂,等.译.北京:科学出版社,2002.32-48,463-470.
〔3〕王世若,王兴龙,韩文瑜.现代动物免疫学〔M〕.第2版.长春:吉林科学技术出版社,2001.465-468.
〔4〕卢圣栋.现代分子生物学实验技术〔M〕.第2版.北京:中国协和医科大学出版社,2001.166-169,197-201,207-213.
〔5〕张守峰,扈荣良,赵君.一个改进的DNA分子量标准物—pT13/HindIIIMarker.中国兽医学报〔J〕2000,20(6):611.
〔6〕YuasaN ,YamaguchiS Complete,Long-lastingprotectionagainstlethalinfectiousbursaldiseaseviruschallengebyasinglevaccinationwithanavianherpesvirusvectorexpressingVP2antigens〔J〕.JVi rol,2002,76(11):5637-5645.
〔7〕ParkerSE ,MonteithD ,HortonH ,etal.SafetyofaGM -CSFadju vant-plasmidDNAmalariavaccine〔J〕.GeneTher,2001,8(13):1011-1023.
〔8〕NicholsWW ,LedwithBJ,ManamSV ,etal.PotentialDNAvaccineintegrationintohostcellgenome〔M〕.AnnalsoftheNewYorkA cademyofSciences,1995,772(1):30-39.
〔9〕LedwithBJ,ManamS ,TroiloPJ ,etal.PlasmidDNAvaccines:assayforintegrationintohostgenomicDNA〔J〕.DevBiol,2000,104:33-43.
〔10〕WangZ ,TroiloPJ ,WangX ,etal.Detectionofintegrationofplas midDNAintohostgenomicDNAfollowingintramuscularinjectionandelectroporation〔J〕.DevBiol,2004,11(8):711-21.
〔11〕LodmellDL ,ParnellMJ,BaileyJR ,etal.One-timegenegunorintramuscularrabiesDNAvaccinationofnon-humanprimates:comparisonofneutralizingantibodyresponsesandprotectionagainstrabiesvirus1yearaftervaccination〔J〕.Vaccine,2002,20:838-844.
〔12〕BoyerJD ,UgenKE ,WangB ,etal.Protectionofchimpanzeesfromhigh doseheterologousHIV -1challengebyDNAvaccination〔J〕.NatMed,3(5):526-532.
〔13〕OsorioJE ,TomlinsonCC ,FrankRS ,etal.ImmunizationofdogsandcatswithaDNAvaccineagainstrabiesvirus〔J〕.Vaccine,1999,17:1109-1116
〔14〕LodmellDL ,EwaltLC .Post-exposureDNAvaccinationprotectsmiceagainstrabiesvirus〔J〕.Vaccine,2001,19:2468-2473.
〔15〕ShuxunRen,MinglinLi,SmithJM ,etal.Low volumejetinjectionforintradermalimmunizationinrabbits〔J〕.BMCBiotechnology,2002,2(1):10-15.
〔16〕LeitnerWW ,YingH ,DriverDA ,etal.Enhancementoftumer spe cificimmuneresponsewithplasmidDNArepliconvectors〔J〕.Can cerRes,2000,60(1):51-55.
〔17〕BosJD ,KapsenbergML .Theskinimmunesystem:progressincu taneousbiology〔J〕.ImmunolToday,1993,14:75-8.
〔18〕BosJD .Theskinasanorganofimmunity〔J〕.ClinExpImmunol,1997,107:3-5.
〔19〕ForgP ,vonHoegenP ,DalemansW ,etal.SuperiorityoftheearpinnaovermuscletissueassiteforDNAvaccination〔J〕.GeneTher,1998,5:789-97.
〔20〕JurianzK ,vonHoegenP ,SchirrmacherV .SuperiorityoftheearpinnaoverasubcutaneoustumourinoculationsiteforinductionofaTh1 typecytokineresponse〔J〕.CancerImmunolImmunother,1998,45(6):327-33.
〔21〕CondonC ,WatkinsSC ,CelluzziCM ,etal.DNA -basedimmuniza tionbyinvivotransfectionofdendriticcells〔J〕.NatMed,1996,2:1122-8.
〔22〕PeachmanKK ,RaoM ,AlvingCR .ImmunizationwithDNAthroughtheskin〔J〕.Methods,2003,31(3):232-242.
〔23〕TutingT .TheimmunologyofcutaneousDNAimmunization〔J〕.CurrOpinMolTher,1999,1(2):216-225.
〔24〕LodmellDL ,ParnellMJ,WeyhrichJT ,etal.CaninerabiesDNAvaccination:asingle doseintradermalinjectionintoearpinnaeelicitselevatedandpersistentlevelsofneutralizingantibody〔J〕.Vaccine,2003,21(25-26):3998-4002.
[1]
刘茜, 朱武洋. 狂犬病治疗方法及抗病毒药物应用的研究进展 [J]. 中国人兽共患病学报, 2021, 37(5): 444-449.
[2]
杨卫红, 杨鹤飞, 冯云, 章域震, 潘虹, 王娟. 云南省2008-2018年人间狂犬病流行特征及狂犬病病毒基因分析 [J]. 中国人兽共患病学报, 2021, 37(4): 339-345.
[3]
梅明珠,杨先锋,龙腾,张琼,赵静,田钦,彭娇娇,罗均,姜贺,林颖仪,林志雄,郭霄峰. 狂犬病病毒HEP-Flury M基因重排在小鼠致病性和保护性研究 [J]. 中国人兽共患病学报, 2020, 36(3): 173-177.
[4]
宋云, 于鹏程, 朱武洋. 人用狂犬病疫苗肌肉注射免疫程序研究进展 [J]. 中国人兽共患病学报, 2020, 36(2): 158-162.
[5]
张莹辉, 姚文生, 康凯, 薛麒, 李启红, 陈小云, 杜吉革, 朱真, 印春生. 狂犬病病毒糖蛋白重组表达及其基因工程疫苗研究进展 [J]. 中国人兽共患病学报, 2020, 36(1): 65-69.
[6]
娄银莹, 周梦洁, 张颖欣, 郑文潇, 于咏兰. 2017-2019北京地区犬钩端螺旋体病流行病学调查 [J]. 中国人兽共患病学报, 2020, 36(1): 56-59.
[7]
章域震, 杨卫红, 张海林, 冯云, 潘虹, 杨丽芬, 王娟, 张云智. “攻击性”在犬类狂犬病监测和临床诊断中的作用与价值评估 [J]. 中国人兽共患病学报, 2019, 35(8): 774-778.
[8]
詹佳飞,宋宏宇,王凝,郭承,李春燕,谢跃,古小彬,杨光友. 基于线粒体ND6基因检测犬感染细粒棘球绦虫的粪便PCR方法 [J]. 中国人兽共患病学报, 2019, 35(7): 626-632.
[9]
齐文静,何黎,王甜,郑雪婷,郭宝平,张文宝,况玲,李军. 细粒棘球绦虫EgM123蛋白融合霍乱毒素B亚单位疫苗的构建表达及免疫原性研究 [J]. 中国人兽共患病学报, 2019, 35(7): 647-654.
[10]
刘志国, 王妙, 崔步云, 李振军. 犬种布病与公共安全风险 [J]. 中国人兽共患病学报, 2019, 35(5): 421-429.
[11]
钟建平, 李睿, 王国松, 洪俊平, 付饶, 陈毅歆. 新城疫病毒株F48E9对CT26小鼠结肠癌的溶瘤治疗作用 [J]. 中国人兽共患病学报, 2019, 35(4): 292-298.
[12]
代军, 马晓春, 赵宇艳, 秦廷洋, 徐磊, 王小兵, 张仕斌. 遵义地区犬狂犬病毒血清抗体流行病学调查与大学生对该病的认知情况分析 [J]. 中国人兽共患病学报, 2019, 35(2): 168-172.
[13]
俞永新, 石磊泰. 中国狂犬病口服疫苗的研究进展及其应用的紧迫性 [J]. 中国人兽共患病学报, 2019, 35(11): 973-980.
[14]
谢渊, 刘淑清, 董国英, 朱武洋. 2004-2018年我国狂犬病疫情时间序列分析 [J]. 中国人兽共患病学报, 2019, 35(11): 1041-1046.
[15]
田登, 刘桂香, 石燕, 姜双应, 赵生仓, 徐莉莉, 张华一, 雷有菊, 旦措, 尕沙, 罗志明. 青藏高原地区Arctic-like狂犬病病毒的分子流行病学研究 [J]. 中国人兽共患病学报, 2018, 34(9): 817-822.